Monday , December 23 2024
Home / admin (page 1479)

admin

Greenliant Launches High Capacity 1TB microSD ArmourDrive(TM) Industrial Memory Cards

About Greenliant By leveraging more than 30 years of solid state storage design expertise, Greenliant is dedicated to developing durable, reliable and secure storage solutions for embedded systems and enterprise datacenters. The company is headquartered in Silicon Valley with product development centers in Santa Clara, Beijing, Shanghai, Xiamen and Hsinchu. https://www.greenliant.com …

Read More »

ANIMAL starring Ranbir Kapoor, Anil Kapoor, Bobby Deol and Parineeti Chopra, directed by Sandeep Reddy Vanga to have a Dusshera 2022 release

. Animal is produced by Bhushan Kumar, Pranay Reddy Vanga, Murad Khetani & Krishan Kumar. FACEBOOK @anilskapoor #RanbirKapoor @ParineetiChopraOfficial @bobbydeol #BhushanKumar @Sandeep Reddy Vanga @Pranay Reddy Vanga #MuradKhetani #KrishanKumar @tseriesfilms @bhadrakalipictures @Cine1StudiosOfficial @tseriesmusic TWITTER @AnilKapoor #RanbirKapoor @ParineetiChopra @thedeol @imvangasandeep #BhushanKumar @VangaPranay @MuradKhetani #KrishanKumar #TSeriesFilms @VangaPictures @Cine1Studios @TSeries @rameemusic @KuttiKalam @dop_santha …

Read More »

Fellows Creative Staff Singapore opened their Singapore office to help the creative content of all businesses stand out in the DX era by sourcing creators and digital talents

SINGAPORE – Media OutReach – 1 March 2021 – With everyone stuck at home during the pandemic,  more people are exposed to many different creative contents  without any doubt.  Netflix is becoming popular and popular, the number of contents has been increasing  inside YouTube, some people are purchasing twice more than usual via Lazada …

Read More »

Novartis Piqray® – First and only treatment specially for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer receives HSA approval[1]

Piqray (alpelisib) is the only treatment approved specifically to address PIK3CA mutation The approval was based on SOLAR-1 Phase III trial showing Piqray plus fulvestrant nearly doubled median PFS (11.0 vs. 5.7 months) in HR+/HER2- advanced breast cancer patients with PIK3CA mutation, compared to fulvestrant alone. Approximately 30-40% of those …

Read More »

ESR selected as a constituent of Hang Seng Composite Index

HONG KONG SAR – Media OutReach – 1 March 2021 – ESR Cayman Limited (“ESR” or the “Company”, together with its subsidiaries as the “Group”; SEHK Stock Code: 1821), the largest APAC focused logistics real estate platform, is pleased to announce that it has been selected as a constituent for the Hang Seng …

Read More »